Trial Profile
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Stomatitis
- Focus Adverse reactions
- Acronyms SWISH
- Sponsors Novartis Pharmaceuticals; Novartis Pharmaceuticals Corporation
- 14 Mar 2017 Results assessing the effect of examethasone-based mouthwash for prevention of stomatitis in patients with breast cancer, published in the Lancet Oncology.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 05 May 2016 Status changed from active, no longer recruiting to completed.